Carrier screening for Tay-Sachs disease

A Commentary on Multiple Screening for Aminoacidopathies in the Newborn Infant.

Canadian Medical Association journal·2010

What we know that could influence future treatment of phenylketonuria.

Journal of inherited metabolic disease·2008

The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

Annals of human genetics·2008

Recommendations for locus-specific databases and their curation.

Human mutation·2007

CpG methylation accounts for a recurrent mutation (c.1222C>T) in the human PAH gene.

Human mutation·2006

After the genome--the phenome?

Journal of inherited metabolic disease·2004

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Correction: Shah et al. Visualization of Critical Limits and Critical Values Facilitates Interpretation. <i>Diagnostics</i> 2025, <i>15</i>, 604.

Diagnostics (Basel, Switzerland)·2026

Effect of basis choice on quantitative parameter estimation in accelerated subspace reconstructions.

Magnetic resonance letters·2026

The two Distinct Functional Lordoses of the Lumbar Spine.

Spine·2026

Refining effect size measures and classification for differential item functioning: Toward unified guidelines across methods.

The British journal of mathematical and statistical psychology·2026

Bayesian and fuzzy hybrid standard setting for pass-fail decisions in clinical examinations.

BMC medical education·2026

Age-range-matched external validation of standard liver volume equations: Methodological re-evaluation of 13 regression models.

PloS one·2026

Related Experiment Videos

Carrier screening for Tay-Sachs disease

Related Concept Videos

A Commentary on Multiple Screening for Aminoacidopathies in the Newborn Infant.

What we know that could influence future treatment of phenylketonuria.

The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

Recommendations for locus-specific databases and their curation.

CpG methylation accounts for a recurrent mutation (c.1222C>T) in the human PAH gene.

After the genome--the phenome?

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Correction: Shah et al. Visualization of Critical Limits and Critical Values Facilitates Interpretation. <i>Diagnostics</i> 2025, <i>15</i>, 604.

Effect of basis choice on quantitative parameter estimation in accelerated subspace reconstructions.

The two Distinct Functional Lordoses of the Lumbar Spine.

Refining effect size measures and classification for differential item functioning: Toward unified guidelines across methods.

Bayesian and fuzzy hybrid standard setting for pass-fail decisions in clinical examinations.

Age-range-matched external validation of standard liver volume equations: Methodological re-evaluation of 13 regression models.

Related Experiment Videos

Carrier screening for Tay-Sachs disease

Related Concept Videos

Related Articles